Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1997-06-20
1999-11-16
Achutamurthy, Ponnathapura
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
424 851, 424 855, 424 856, 424 857, 514 2, 514 12, 514 21, 530351, 530402, 530406, A61K 3821, C07K 1452, C07K 1708
Patent
active
059852658
ABSTRACT:
Provided herein are methods and compositions relating to the attachment of water soluble polymers to proteins. Provided are novel methods for N-terminally modifying proteins or analogs thereof, and resultant compositions, including novel chemically modified G-CSF compositions and related methods of preparation. Also provided is chemically modified consensus interferon.
REFERENCES:
patent: 4002531 (1977-01-01), Royer
patent: 4766106 (1988-08-01), Katre et al.
patent: 5252714 (1993-10-01), Harris et al.
patent: 5372808 (1994-12-01), Blatt et al.
patent: 5382657 (1995-01-01), Karasiewicz et al.
DePrince Randolph B.
Farrar Christine E.
Gabriel Nancy E.
Kinstler Olaf B.
Achutamurthy Ponnathapura
Amgen Inc.
Crandall Craig A.
Levy Ron K.
Odre Steven M.
LandOfFree
N-terminally chemically modified protein compositions and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-terminally chemically modified protein compositions and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-terminally chemically modified protein compositions and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1320607